About this trial
This case-control study aims to detect the presence and density of Demodex mites in patients with acne, identify the species using molecular methods, and evaluate the in vitro survival time of live mites exposed to medicinal herbal extracts.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
- Age 18 to 45 years
Clinically diagnosed acne vulgaris of any severity (cases)
Age- and sex-matched healthy individuals without dermatosis or pruritus (controls)
Written informed consent
Disqualifiers
- Use of topical anti-acne or acaricidal treatments within the last 4 weeks
Use of systemic antibiotics or systemic retinoids within the last 3 months
Trial population
Adult patients with clinically diagnosed acne vulgaris attending the dermatology outpatient clinic at Assiut University Hospital, and age- and sex-matched healthy controls.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Prevalence of Demodex infestation
Proportion of participants with Demodex mites detected by standardized skin surface biopsy.
Mean Demodex density
Mean number of Demodex mites per cm² of skin surface.
Mean in vitro survival time of Demodex mites
Mean survival time in minutes of live Demodex mites exposed to the medicinal herbal extracts.
Secondary outcomes
Distribution of Demodex species
Frequency and percentage of Demodex folliculorum and Demodex brevis among positive cases identified by PCR.
Mean mite density according to acne severity
Mean Demodex density (mites/cm²) in mild, moderate, and severe acne groups according to the Global Acne Grading System.
Mean survival time at 5% herbal extract concentration
Mean survival time in minutes of Demodex mites exposed to 5% concentration of the herbal extract
Mean survival time at 10% herbal extract concentration
Mean survival time in minutes of Demodex mites exposed to 10% concentration of the herbal extract.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: